China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina, just minutes ...

whole-transcriptome sequencing, and epigenetic analysis. The NovaSeq X Plus instrument is now available and ready for submissions! The 2-channel chemistry, patterned flow-cells are best for large ...

These solutions leverage the power of Illumina's leading NovaSeq X series platform and ... and software offerings that support its core sequencing and multiomics businesses. Each of these efforts ...

The import ban on Illumina's NGS sequencers follows its placement on China's Ministry of Commerce's (MOFCOM) ‘Unreliable Entity List’ last month. Image credit: JHVEPhoto via Shutterstock.

The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...

Now, Illumina CEO Jacon Thaysen said the company will focus its attention elsewhere—in other international markets, as well as by adding new capabilities to its sequencer platforms.

Illumina is raising the curtain on its upcoming ... The company said its spatial technology will run on its current NextSeq and NovaSeq hardware through a new multimodal software platform, with ...

it took Illumina five years to develop its latest sequencing platform, the NovaSeq X, which we use as a barometer for how long it could take for a competitor to engineer a similar product.